Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what recent discussions he has had with NICE on the potential merits of producing guidance on the use of (a) Orlissa, (b) Visanne and (c) other endometriosis drugs.

There have been no recent discussions. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing authoritative, evidence-based recommendations for the National Health Service on whether new medicines represent a clinically and cost-effective use of resources. All new medicines are routinely considered through the established topic selection arrangements for the development of NICE’s guidance.